MaxCyte Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-37.92	-23.57	-19.08	-11.82	-12.9
Depreciation & Amortization	4.57	3.47	1.42	1.05	0.61
Share-Based Compensation	13.98	11.75	7.96	2.47	1.75
Other Operating Activities	-2.31	-6.43	-0.98	-0.49	1.73
Operating Cash Flow	-21.69	-14.78	-10.68	-8.78	-8.8
Capital Expenditures	-3.69	-18.48	-3.83	-2.07	-1.27
Change in Investments	58.68	-6.35	-191.18	-14.51	1.73
Investing Cash Flow	54.98	-24.82	-195.01	-16.58	0.45
Share Issuance / Repurchase	2.14	2.89	239.71	28.97	12.46
Debt Issued / Paid	0	0	-4.99	-0.06	-0.15
Financing Cash Flow	2.14	2.89	234.72	28.9	12.31
Net Cash Flow	35.44	-36.72	29.03	3.54	3.96
Free Cash Flow	-25.38	-33.26	-14.51	-10.85	-10.07
Free Cash Flow Margin	-61.46%	-75.15%	-42.81%	-41.48%	-46.59%
Free Cash Flow Per Share	-0.25	-0.33	-0.16	-0.16	-0.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).